CI
RVPH

Cowen Inc’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Cowen Inc’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.8M Buy
8,750
+7,050
+415% +$1.43M 0.13% 124
2019
Q1 		$342K Buy
1,700
+445
+35% +$89.2K 0.04% 175
2018
Q4 		$246K Buy
+1,255
New +$246K 0.03% 209

Other funds holding RVPH

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cowen Inc's RVPH Position: Q2 2019 in Review

Cowen Inc increased its REVIVA PHARMA HLDGS INC (RVPH) stake by 415% in Q2 2019, buying an estimated $1.43M and bringing the position to 8,750 shares worth $1.8M. The position accounts for 0.13% of the portfolio, ranked #124.

Cowen Inc first reported a position in RVPH in Q4 2018 and has held it in 3 quarters since. 21 funds tracked by Wall St. Rank hold RVPH as of Q2 2019.

  • Cowen Inc held 8,750 shares of REVIVA PHARMA HLDGS INC worth $1.8M as of Q2 2019.
  • Cowen Inc bought 7,050 REVIVA PHARMA HLDGS INC shares in Q2 2019, an estimated $1.43M.
  • REVIVA PHARMA HLDGS INC made up 0.13% of Cowen Inc's portfolio in Q2 2019, its #124 holding.
  • Cowen Inc first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and has held it in 3 quarters since.
  • 21 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.